imotun
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
2
Earliest trial started Dec 1, 2012 (NCT01743287)
Timeline
No events for the selected filters.
Indications
Approved for
Studied for
Mechanism of action
- Glycogen synthase kinase-3 alphaINHIBITOR
GSK3A inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- imotun
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01756937 | Phase 4 | Jan 1, 2013 | Chong Kun Dang Pharmaceutical, Hanyang University |
| NCT01743287 | Phase 4 | Dec 1, 2012 | Chong Kun Dang Pharmaceutical, Seoul National University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chong Kun Dang Pharmaceutical | For profit | 2 | 2 | 1 | 2012 |
| Hanyang University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Seoul National University | Academic/Hospital | 1 | 0 | 1 | 2012 |
3 organizations
Page 1 / 1